1. Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

   • Allison B. Reiss
   • Elzbieta Wirkowski

   Current Opinion 14 September 2012 Pages: 2111 - 2120

2. Recent Advances in the Pharmacological Management of Pain

   • Josée Guindon
   • Jean-Sébastien Walczak
   • Pierre Beaulieu

   Leading Article 14 September 2012 Pages: 2121 - 2133

3. Modern Management of Small-Cell Lung Cancer

   • Roberta Ferraldeschi
   • Sofia Baka
   • Paul Lorigan

   Therapy in Practice 14 September 2012 Pages: 2135 - 2152

4. Treatment of Acute Lymphoblastic Leukaemia

   • Effrosyni Apostolidou
   • Ronan Swords
   • Francis J. Giles

   Review Article 14 September 2012 Pages: 2153 - 2171

5. Current Management Strategies for Intraocular Retinoblastoma

   • Jonathan W. Kim
   • David H. Abramson
   • Ira J. Dunkel

   Review Article 14 September 2012 Pages: 2173 - 2185

6. Topical Imiquimod

   • Antona J. Wagstaff
   • Caroline M. Perry

   Adis Drug Evaluation 14 September 2012 Pages: 2187 - 2210

7. Deferasirox

   • Lily P. H. Yang
   • Susan J. Keam
   • Gillian M. Keating

   Adis Drug Evaluation 14 September 2012 Pages: 2211 - 2230

8. Topiramate

   • Katherine A. Lyseng-Williamson
   • Lily P. H. Yang

   Adis Drug Evaluation 14 September 2012 Pages: 2231 - 2256

9. Trabectedin

   • Natalie J. Carter
   • Susan J. Keam

   Adis Drug Evaluation 14 September 2012 Pages: 2257 - 2276

10. Maraviroc

    • Natalie J. Carter
    • Gillian M. Keating

    Adis Drug Profile 14 September 2012 Pages: 2277 - 2288

11. Maraviroc

    • Mark Nelson

    Adis Drug Profile 14 September 2012 Pages: 2289 - 2289

12. Maraviroc

    • Jacob Lalezari

    Adis Drug Profile 14 September 2012 Pages: 2289 - 2289

13. Maraviroc

    • Gerd Fätkenheuer

    Adis Drug Profile 14 September 2012 Pages: 2289 - 2290

14. Pharmacological Neuroprotection for Glaucoma

    • Gábor Holló

    Correspondence 14 September 2012 Pages: 2291 - 2291